Skip to content

Effect of dry needling in treatment of scar

The effectiveness of dry needling on scar tissue: a randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130409012953N4
Enrollment
80
Registered
2023-08-21
Start date
2023-09-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar tissue. Scar conditions and fibrosis of skin

Interventions

Intervention 1: Intervention group: Dry needling therapy in the true dry needling group along with routine physiotherapy is performed by inserting a 2 cm Dung bang brand needle at an angle of about 15

Sponsors

Deputy of Research of Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Longitudinal scar tissue older than six weeks No contraindication for joint active and passive movements near the scar tissue Age between 20-60 years

Exclusion criteria

Exclusion criteria: Trypanophobia Skin problems (such as infection, wounds, atopic dermatitis)

Design outcomes

Primary

MeasureTime frame
The flexibility of the scar tissue. Timepoint: At the start of the study (prior to the intervention), immediately following the final treatment session, and two weeks after the completion of the treatment sessions. Method of measurement: Tissue compliance meter.

Secondary

MeasureTime frame
Active and passive joint range of motion. Timepoint: At the start of the study (prior to the intervention), immediately following the final therapy session, and two weeks after the completion of the treatment sessions. Method of measurement: Universal goniometer.;Pain. Timepoint: At the start of the study (prior to the intervention), immediately following the final therapy session, and two weeks after the completion of the treatment sessions. Method of measurement: Numeric pain rating scale.;Functional disability. Timepoint: At the start of the study (prior to the intervention), immediately following the final therapy session, and two weeks after the completion of the treatment sessions. Method of measurement: SF-36 questionnaire.

Countries

Iran (Islamic Republic of), United States of America

Contacts

Public ContactMohammadreza Pourahmadi

Iran University of Medical Sciences

pourahmadipt@gmail.com+98 21 2222 2059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Sep 12, 2026